Coronavirus News and Research

RSS
Immunobridging study shows immunogenicity in adolescents receiving SARS-CoV-2 mRNA and inactivated vaccines

Immunobridging study shows immunogenicity in adolescents receiving SARS-CoV-2 mRNA and inactivated vaccines

14 Mar 2022
The impact of PLEX on the survival of patients with severe COVID-19 and the effect on the cytokine release syndrome

The impact of PLEX on the survival of patients with severe COVID-19 and the effect on the cytokine release syndrome

14 Mar 2022
Pangolins confiscated from illegal wildlife trade in Viet Nam host SARS-CoV-2 related coronaviruses

Pangolins confiscated from illegal wildlife trade in Viet Nam host SARS-CoV-2 related coronaviruses

11 Mar 2022
Modifying red blood cells to create a promising new vehicle for vaccine delivery

Modifying red blood cells to create a promising new vehicle for vaccine delivery

11 Mar 2022
Exploring SARS-CoV-2 spike evolution in relation to sensitivity to antiviral restriction factors

Exploring SARS-CoV-2 spike evolution in relation to sensitivity to antiviral restriction factors

11 Mar 2022
In silico screening and testing of FDA approved drugs inhibiting SARS-CoV-2 spike protein cleavage

In silico screening and testing of FDA approved drugs inhibiting SARS-CoV-2 spike protein cleavage

11 Mar 2022
Meta-analysis finds intensified anticoagulation had no effect on short term mortality among hospitalized COVID-19 patients

Meta-analysis finds intensified anticoagulation had no effect on short term mortality among hospitalized COVID-19 patients

11 Mar 2022
Study indicates a 100 µg mRNA-1273 booster has acceptable safety and robust antibody response against SARS-CoV-2

Study indicates a 100 µg mRNA-1273 booster has acceptable safety and robust antibody response against SARS-CoV-2

11 Mar 2022
Novel genetic relationships with severe SARS-CoV-2

Novel genetic relationships with severe SARS-CoV-2

11 Mar 2022
Updated results from ongoing study on the effect of a BNT162b2 booster dose on anti-SARS-CoV-2 antibodies

Updated results from ongoing study on the effect of a BNT162b2 booster dose on anti-SARS-CoV-2 antibodies

11 Mar 2022
Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

11 Mar 2022
Potent pan-β-CoV human monoclonal antibody has in vivo activity in multiple animal models

Potent pan-β-CoV human monoclonal antibody has in vivo activity in multiple animal models

11 Mar 2022
Study shows SARS-CoV-2 infection induces global alterations of the host endomembrane system

Study shows SARS-CoV-2 infection induces global alterations of the host endomembrane system

11 Mar 2022
Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

11 Mar 2022
Further optimization of cysteine-reactive pyrazoline-based covalent inhibitors for the SARS-CoV-2 Mpro

Further optimization of cysteine-reactive pyrazoline-based covalent inhibitors for the SARS-CoV-2 Mpro

11 Mar 2022
Study shows competitive fitness of emerging SARS-CoV-2 variants linked to their distinctiveness relative to identified lineages

Study shows competitive fitness of emerging SARS-CoV-2 variants linked to their distinctiveness relative to identified lineages

11 Mar 2022
KHN’s ‘What the Health?’: Congress shelves covid funding for now

KHN’s ‘What the Health?’: Congress shelves covid funding for now

10 Mar 2022
Natural SARS-CoV-2 infection-induced anti-spike antibody responses

Natural SARS-CoV-2 infection-induced anti-spike antibody responses

10 Mar 2022
Origins and evolutions of SARS-CoV-2 Alpha variant in the UK

Origins and evolutions of SARS-CoV-2 Alpha variant in the UK

10 Mar 2022
LMU scientists find specific immunological signature that can prevent SARS-CoV-2 virus spread

LMU scientists find specific immunological signature that can prevent SARS-CoV-2 virus spread

10 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback